NM_030952.3(NUAK2):c.1535C>T (p.Ala512Val) AND not specified
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 4, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004289585.1
Allele description [Variation Report for NM_030952.3(NUAK2):c.1535C>T (p.Ala512Val)]
NM_030952.3(NUAK2):c.1535C>T (p.Ala512Val)
Condition(s)
- Synonyms:
- AllHighlyPenetrant
- Identifiers:
- MedGen: CN169374
-
Rattus norvegicus phospholipase C-like 1 (Plcl1), mRNA
Rattus norvegicus phospholipase C-like 1 (Plcl1), mRNAgi|1937867796|ref|NM_053456.2|Nucleotide
-
Rattus norvegicus insulin induced gene 1 (Insig1), mRNA
Rattus norvegicus insulin induced gene 1 (Insig1), mRNAgi|1937906946|ref|NM_022392.2|Nucleotide
-
PREDICTED: Homo sapiens calcium voltage-gated channel subunit alpha1 C (CACNA1C)...
PREDICTED: Homo sapiens calcium voltage-gated channel subunit alpha1 C (CACNA1C), transcript variant X24, mRNAgi|2462497938|ref|XM_054332309.1|Nucleotide
-
interleukin-1 receptor type 2 isoform X8 [Homo sapiens]
interleukin-1 receptor type 2 isoform X8 [Homo sapiens]gi|2462576991|ref|XP_054199809.1|Protein
-
LOC129660770 [Homo sapiens]
LOC129660770 [Homo sapiens]Gene ID:129660770Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024